Kenya - English - Pharmacy and Poisons Board

cachet pharmaceuticals pvt. ltd 415, shah nahar, worli, mumbai-400018 - ofloxacin & ornidazole tablets with lactic acid… - tablet - ofloxacin 200mg, ornidazole 500mg, lactic acid… - antiprotozoals agents against amoebiasis and

United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - tablet - 7.5 mg - carefully consider the potential benefits and risks of meloxicam tablets and other treatment options before deciding to use meloxicam tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis and rheumatoid arthritis. meloxicam tablet is contraindicated in patients with known hypersensitivity to meloxicam. meloxicam tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions, and precautions, pre-existing asthma). meloxicam tablet is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings).

United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - flurbiprofen (unii: 5gro578klp) (flurbiprofen - unii:5gro578klp) - tablet - 50 mg - carefully consider the potential benefits and risks of flurbiprofen tablet, usp and other treatment options before deciding to use flurbiprofen tablet, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). flurbiprofen tablet, usp is indicated: - for relief of the signs and symptoms of rheumatoid arthritis. - for relief of the signs and symptoms of osteoarthritis. flurbiprofen tablets, usp are contraindicated in patients with known hypersensitivity to flurbiprofen. flurbiprofen tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nonsteroidal anti-inflammatory drugs. severe, rarely fatal, anaphylactic-like reactions to nonsteroidal anti-inflammatory drugs have been reported in such patients (see warnings, anaphylactoid reactions, and precautions, preexisting asthma). flurbiprofen tablet, usp is contraindicated for the treatment of peri-operative pain

United States - English - NLM (National Library of Medicine)

dr. reddy's laboratories limited - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - tablet - 7.5 mg - carefully consider the potential benefits and risks of meloxicam tablets and other treatment options before deciding to use meloxicam tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis. meloxicam tablets are contraindicated in patients with known hypersensitivity to meloxicam. meloxicam tablet should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions, and precautions, pre-existing asthma ). meloxicam tablets are contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings ).

United States - English - NLM (National Library of Medicine)

dr. reddy's laboratories limited - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - tablet, film coated - 400 mg - carefully consider the potential benefits and risks of ibuprofen tablets and other treatment options before deciding to use ibuprofen. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibuprofen tablets are indicated for relief of mild to moderate pain. ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets in children have not been conducted. ibuprofen tablets are contraindicated in patients with known hypersensitivity to ibuprofen. ibuprofen tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reac

United States - English - NLM (National Library of Medicine)

watson labs - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - tablet - 250 mg - carefully consider the potential benefits and risks of naproxen and other treatment options before deciding to use naproxen. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). naproxen tablets are indicated: - for relief of mild to moderate pain for relief of mild to moderate pain - for relief of signs and symptoms of juvenile arthritis for relief of signs and symptoms of juvenile arthritis - for relief of the signs and symptoms of rheumatoid arthritis for relief of the signs and symptoms of rheumatoid arthritis - for relief of the signs and symptoms of osteoarthritis for relief of the signs and symptoms of osteoarthritis - for treatment of primary dysmenorrhea for treatment of primary dysmenorrhea - for acute or long-term use in the relief of signs and symptoms of the following: ankylosing spondylitis acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis) acute gouty arthritis for acute or long-

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - diflunisal 250mg - tablet - 250 mg - active: diflunisal 250mg excipient: hyprolose magnesium stearate microcrystalline cellulose starch

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - diflunisal 500mg - tablet - 500 mg - active: diflunisal 500mg

United States - English - NLM (National Library of Medicine)

ranbaxy pharmaceuticals inc. - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - tablet - 7.5 mg - carefully consider the potential benefits and risks of meloxicam and other treatment options before deciding to use meloxicam. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). meloxicam is indicated for relief of the signs and symptoms of osteoarthritis. meloxicam is contraindicated in patients with known hypersensitivity to meloxicam. meloxicam should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings , anaphylactoid reactions , and precautions , pre-existing asthma ). meloxicam is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (see warnings ).

United States - English - NLM (National Library of Medicine)

watson laboratories inc. - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - tablet - 7.5 mg - carefully consider the potential benefits and risks of meloxicam and other treatment options before deciding to use meloxicam. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (seewarnings ). meloxicam is indicated for relief of the signs and symptoms of osteoarthritis. meloxicam is contraindicated in patients with known hypersensitivity to meloxicam. meloxicam should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (seewarnings, anaphylactoid reactions , andprecautions, pre-existing asthma ). meloxicam is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (cabg) surgery (seewarnings ).